Memorial Sloan Kettering Cancer Center
Supporter
Dedicated to excellence in caring for patients through treatment, research and education
Membership discount for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, a membership discount is available on your APC.
Please follow the submission guidelines to benefit from this membership discount.
Memorial Sloan Kettering Cancer Center's Articles
Page 3 of 45
-
Citation: Journal of Hematology & Oncology 2024 17:89
-
Charting the metabolic biogeography of the colorectum in cancer: challenging the right sided versus left sided classification
Citation: Molecular Cancer 2024 23:211 -
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Citation: BMC Medical Informatics and Decision Making 2024 24:272 -
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
Citation: Acta Neuropathologica Communications 2024 12:151 -
Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Citation: Genome Medicine 2024 16:108 -
Utilizing a patient advocacy-led clinical network to engage diverse, community-based sites in implementation-effectiveness research
Citation: BMC Health Services Research 2024 24:891 -
SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Citation: Journal of Hematology & Oncology 2024 17:58 -
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC
Citation: Journal of Hematology & Oncology 2024 17:56 -
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
Citation: BMC Cancer 2024 24:901 -
A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)
Citation: BMC Cancer 2024 23(Suppl 1):1253 -
Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
Citation: BMC Urology 2024 24:151 -
Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description
Citation: Perioperative Medicine 2024 13:79 -
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Citation: Genome Biology 2024 25:191 -
Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis
Citation: Journal of Translational Medicine 2024 22:567 -
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019
Citation: Breast Cancer Research 2024 26:101 -
Mentor communication skills training: development, feasibility, and preliminary efficacy
Citation: BMC Medical Education 2024 24:646 -
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
Citation: Journal of Hematology & Oncology 2024 17:42 -
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Citation: Molecular Cancer 2024 23:115 -
Outcome of patients with perihilar cholangiocarcinoma and previous biliary instrumentation: an observational study
Citation: BMC Gastroenterology 2024 24:181 -
Author Correction: Epiphany: predicting Hi-C contact maps from 1D epigenomic signals
Citation: Genome Biology 2024 25:132